Laboratory & Reagent Supply for Rare Cancer Research

The contract titled Laboratory & Reagent Supply for Rare Cancer Research requires the provision of specialized reagents, cell lines, laboratory equipment, and consumables essential for conducting rare cancer research. These materials must meet rigorous scientific and quality standards to support precise, reproducible experimental outcomes in a high-stakes research environment. The supply chain must ensure consistent availability, proper storage conditions, and timely delivery to maintain the integrity of ongoing studies, with all items aligned to the specific protocols and requirements of the research program. Issued as a subcontract under the Department of the Army - USAMRAA within the Department of Defense, the solicitation is categorized under NAICS code 424690, indicating its focus on medical and laboratory equipment and supplies distribution. The opportunity was posted on June 17, 2026, with a firm response deadline of September 30, 2026. There is no designated set-aside classification, and performance is expected to support operations tied to the awarding agency’s research objectives, though the precise location of performance is not specified. Interested parties must submit proposals before the deadline to qualify for consideration, ensuring alignment with the agency’s mission to advance critical biomedical research in rare cancers.